Audited Report & Accounts published on website

RNS Number : 4797L

Immupharma PLC

30 April 2020

 

RNS: RELEASE  30 April 2020

ImmuPharma PLC

("ImmuPharma" or the "Company")

Audited Report & Accounts published on website

ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company confirms that the Audited Annual Report and Accounts ("Report") for the year ended 31 December 2019, has today been published on the Company's website. Copies of this Report, including the Notice of Annual General Meeting, will be posted to shareholders in the near future.

Confirmation of this date will be announced to the market on the day of posting. To view the Report please go to: www.immupharma.co.uk.

For further information please contact: ImmuPharma PLC ( www.immupharma.com ) Tim McCarthy, Chairman + 44 (0) 207 152 4080 Dimitri Dimitriou, Chief Executive Officer Lisa Baderoon, Head of Investor Relations + 44 (0) 7721 413496 SPARK Advisory Partners Limited (NOMAD) Neil Baldwin Stanford Capital Partners (Joint Broker) Patrick Claridge, John Howes SI Capital (Joint Broker) Nick Emerson [phone] [phone] [phone] 4Reliance (Euronext Growth Listing Sponsor) Jean-Charles Snoy Degroof Petercam (Liquidity Provider) Erik De Clippel Backstage Communication Olivier Duquaine Gunther De Backer [phone] [phone] [phone] [phone]

 

END

 

 

ACSIMMPTMTAJMJM